Cargando…

Synuclein Motor Dysfunction Composite Scale for the Discrimination of Dementia With Lewy Bodies From Alzheimer’s Disease

BACKGROUND: An abnormal increase of α-synuclein in the brain is the hallmark of dementia with Lewy bodies (DLB). However, the diagnostic power of plasma α-synuclein in DLB is not yet confirmed. Parkinsonism is highly associated with and is one of the core clinical features of DLB. We studied plasma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ying-Tsung, Orimo, Satoshi, Wei, Cheng-Yu, Hung, Guang-Uei, Yang, Shieh-Yueh, Chiu, Pai-Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161692/ https://www.ncbi.nlm.nih.gov/pubmed/35663565 http://dx.doi.org/10.3389/fnagi.2022.920591

Ejemplares similares

Motor Dysfunction Questionnaire and Dopamine Transporter Imaging Composite Scale Improve Differentiating Dementia With Lewy Bodies From Alzheimer's Disease With Motor Dysfunction
por: Chiu, Pai-Yi, et al.
Publicado: (2021)

Reduced vascular risk factors in Parkinson's disease dementia and dementia with Lewy bodies compared to Alzheimer's disease
por: Chan, Po‐Chi, et al.
Publicado: (2018)

Freezing of Speech Single Questionnaire as a Screening Tool for Cognitive Dysfunction in Patients With Dementia With Lewy Bodies
por: Chiu, Pai-Yi, et al.
Publicado: (2020)

Association of visual hallucinations with very mild degenerative dementia due to dementia with Lewy bodies
por: Lin, Wei, et al.
Publicado: (2018)

The Feasibility of Differentiating Lewy Body Dementia and Alzheimer’s Disease by Deep Learning Using ECD SPECT Images
por: Ni, Yu-Ching, et al.
Publicado: (2021)

Time Perception in Prodromal Alzheimer's Dementia and in Prodromal Dementia With Lewy Bodies
por: Pai, Ming-Chyi, et al.
Publicado: (2021)

An Informant-Based Simple Questionnaire for Visuospatial Dysfunction Assessment in Dementia
por: Wang, Ching-Tsu, et al.
Publicado: (2020)

Network dysfunction in α‐synuclein transgenic mice and human Lewy body dementia
por: Morris, Meaghan, et al.
Publicado: (2015)

Depression in dementia with Lewy bodies: A comparison with Alzheimer's disease
por: Chiu, Pai-Yi, et al.
Publicado: (2017)

Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s Disease
por: Koehler, Niklas K. U., et al.
Publicado: (2013)

Tremor in Vascular Cognitive Impairment Raises the Possibility of Mixed Pathology With Lewy Body Disease
por: Chiu, Pai-Yi, et al.
Publicado: (2020)

α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies
por: Kasuga, Kensaku, et al.
Publicado: (2012)

Visual hallucinations in Alzheimer's disease is significantly associated with clinical diagnostic features of dementia with Lewy bodies
por: Chiu, Pai-Yi, et al.
Publicado: (2017)

Platelet miRNA Biosignature Discriminates between Dementia with Lewy Bodies and Alzheimer’s Disease
por: Gámez-Valero, Ana, et al.
Publicado: (2021)

Optimized Cingulate Island Sign in Discriminating Dementia With Lewy Bodies From Alzheimer Disease
por: Ge, Jingjie, et al.
Publicado: (2023)

Efficacy of Adjunctive Therapy with Zonisamide Versus Increased Dose of Levodopa for Motor Symptoms in Patients with Dementia with Lewy Bodies: The Randomized, Controlled, Non-Inferiority DUEL Study
por: Ikeda, Manabu, et al.
Publicado: (2023)

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
por: Hansson, Oskar, et al.
Publicado: (2014)

Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
por: Chiu, Pai-Yi, et al.
Publicado: (2022)

Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer’s Disease in Clinical Practice
por: Lilamand, Matthieu, et al.
Publicado: (2022)

CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease
por: del Campo, Marta, et al.
Publicado: (2023)

Real-World Testing of a Machine Learning–Derived Visual Scale for Tc99m TRODAT-1 for Diagnosing Lewy Body Disease: Comparison with a Traditional Approach Using Semiquantification
por: Chiu, Pai-Yi, et al.
Publicado: (2022)

Neural correlates of attention‐executive dysfunction in lewy body dementia and Alzheimer's disease
por: Firbank, Michael, et al.
Publicado: (2015)

Structural Brain Correlates of Attention Dysfunction in Lewy Body Dementias and Alzheimer’s Disease
por: Cromarty, Ruth A., et al.
Publicado: (2018)

α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies
por: van Steenoven, Inger, et al.
Publicado: (2018)

A toxic subset of soluble α-synuclein species in dementia with Lewy body
por: Castillo-Carranza, Diana L
Publicado: (2020)

α-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox
por: Simon, Christopher, et al.
Publicado: (2021)

Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies
por: Koss, David J., et al.
Publicado: (2022)

Neuropsychiatric Symptoms in Parkinson’s Disease Dementia Are More Similar to Alzheimer’s Disease than Dementia with Lewy Bodies: A Case-Control Study
por: Chiu, Pai-Yi, et al.
Publicado: (2016)

The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
por: Schulz-Schaeffer, Walter J.
Publicado: (2010)

The Diagnostic Value of CSF α-Synuclein in the Differential Diagnosis of Dementia with Lewy Bodies vs. Normal Subjects and Patients with Alzheimer’s Disease
por: Kapaki, Elisabeth, et al.
Publicado: (2013)

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia
por: Chiasserini, Davide, et al.
Publicado: (2017)

Delusions in Patients with Dementia with Lewy Bodies and the Associated Factors
por: Tzeng, Ray-Chang, et al.
Publicado: (2018)

The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders
por: Irwin, David J., et al.
Publicado: (2018)

Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology
por: Ngolab, Jennifer, et al.
Publicado: (2017)

Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies
por: Perra, Daniela, et al.
Publicado: (2021)

Quantifying regional α ‐synuclein, amyloid β, and tau accumulation in lewy body dementia
por: Miller, Rebecca L., et al.
Publicado: (2022)

Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue
por: Dhavale, Dhruva D., et al.
Publicado: (2023)

Absence of Alpha-Synuclein Pathology in the Stomach of a Patient With Prodromal Dementia With Lewy Bodies
por: Shin, Chaewon, et al.
Publicado: (2023)

Structural correlates of attention dysfunction in Lewy body dementia and Alzheimer’s disease: an ex-Gaussian analysis
por: Schumacher, Julia, et al.
Publicado: (2019)

Improving the identification of dementia with Lewy bodies in the context of an Alzheimer’s-type dementia
por: Thomas, Alan J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_09epicna90kqulascamg7ml6ak